DocGo, Inc. provides mobile health services and integrated medical mobility solutions in 26 states in the United States and the United Kingdom. The company's AI-powered transportation and concierge medical services enable its clinical professionals to facilitate patient-centered care, helping improve patient outcomes while reducing the total cost of care for its customers. It also provides medical transport services. As of October 1, 2021, the company had 3,500 medical providers. It serves facilities, hospital networks, and health insurance providers. The company was founded in 2015 and is headquartered in New York, New York.
IPO Year: 2020
Exchange: NASDAQ
Website: docgo.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/18/2023 | $15.00 | Buy | BTIG Research |
| 4/21/2023 | $11.00 | Overweight | Cantor Fitzgerald |
| 4/19/2022 | $11.00 | Buy | Deutsche Bank |
| 1/19/2022 | $14.00 | Buy | Stifel |
| 12/21/2021 | $13.00 | Buy | Canaccord Genuity |
| 12/7/2021 | $14.00 | Buy | Needham |
| 11/30/2021 | $16.00 → $22.00 | Outperform | Northland Capital Markets |
| 11/30/2021 | $14.00 | Overweight | Barclays |
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
3 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenue for the third quarter of 2024 was $138.7 million, compared to $186.6 million in the third quarter of 2023, a decrease of 26%. The decline was primarily due to the planned wind down of migrant-related progra
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, November 7, 2024 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) A webcast of the conference call can be accessed under Events on the Investors section of the Company's
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1 Guidance of $65-$75 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gros
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the second quarter ended June 30, 2024 after the markets close on Wednesday, August 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, August 7, 2024 5:00 p.m. ET 1-877-343-4136 (U.S.) 1-203-518-9843 (international) Conference ID: DOCGO A webcast of the conference call can be accessed under Events on the Investors sectio
Company Reports First Quarter Net Income of $10.6 Million and Record Adjusted EBITDA1 of $24.1 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Total revenue for the first quarter of 2024 was $192.1 million, compared to $113.0 million in the first quarter of 2023, an increase of 70%. Gross margin for the first quarter of 2024 was 35.0%, compared to the gross margin in the first quarter of 2023 of 28.1%.
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2024 after the markets close on Wednesday, May 8, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, May 8, 2024 5:00 p.m. ET 1-877-407-0784 (U.S.) 1-201-689-8560 (international) Conference ID: 13745526 To access the Call me™ feature, which avoids the need to wait for an operator, click here.
Company Updates 2024 Revenue Guidance to $720-$750 Million, Introduces 2024 Adjusted EBITDA Guidance1 of $80-$85 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services in 30 states and the UK, today announced financial and operating results for the quarter and year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Total revenues for the fourth quarter of 2023 were $199.2 million, compared to $108.8 million in the fourth quarter of 2022, an increase of 83%. Gross margin for the fourth quarter of 2023 was 33.5%, compared
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2023 after the markets close on Wednesday, February 28, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, February 28, 2024 5:00 p.m. ET 1-877-407-0784 (U.S.) 1-201-689-8560 (international) Conference ID: 13743132 To access the Call me™ feature, which avoids the need to wai
Company Raises 2023 Revenue Guidance to $615-$625 Million, up From a Previous Range of $540-$550 Million And Increases Adjusted EBITDA1 Guidance to $50-$55 Million, up From a Previous Range of $48-$53 Million Management to Host Conference Call and Webcast Today at 5:00 p.m. EDT DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2023. Q3 2023 Financial Highlights Total revenue for the third quarter of 2023 was $186.6 million, up 49% from $125.5 million in the second quarter of 2023 and up 79% from $104.3 million in the third quarter
Management to host conference call and webcast at 5:00 p.m. EDT on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that the Company will release its financial results for the third quarter ended September 30, 2023 after the markets close on Monday, November 6, 2023. Management will also host a conference call to discuss these results at 5:00 p.m. EDT on that day. Conference call and webcast details: Monday, November 6, 2023 5:00 p.m. EDT 1-877-407-0784 (U.S.) 1-201-689-8560 (international) Conference ID: 13741345 To access the Call me™ feature, which avoids the need to wait for an operator,
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"),a leading provider of technology-enabled mobile health services, today announced it has secured five new contracts that include remote patient monitoring (RPM), virtual care management (VCM), chronic care management (CCM), cardiac implantable electronic device (CIED), and a care gap closure program for a national health plan. These noteworthy examples of new DocGo contracts expand the Company's reach and ability to deliver quality virtual, in-person, and mobile healthcare services.
BTIG analyst David Larsen maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $11 to $7.
Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $9 to $5.
Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $10 to $7.
Cantor Fitzgerald analyst Sarah James maintains DocGo (NASDAQ:DCGO) with a Overweight and lowers the price target from $11 to $5.
2024 GuidanceGiven that the previously forecasted wind-down of migrant related services has been accelerated, the Company is revising 2024 revenue guidance from $720-$750 million to $600-$650 million, with an expected contribution of $320-350 million of migrant-related revenue in 2024 from contracts with New York City Housing Preservation and Development and New York City Health and Hospitals.The revenue expectation for our 2024 base businesses going forward – medical transportation and non-migrant mobile health – is $280 - $300 million, in line with our previous expectations. In 2025, the Company expects this base business to grow in excess of 30%, with an adjusted EBITDA margin2 in excess
DocGo (NASDAQ:DCGO) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 percent. The company reported quarterly sales of $192.10 million which beat the analyst consensus estimate of $187.93 million by 2.22 percent. This is a 70.00 percent increase over sales of $113.00 million the same period last year.
In the last three months, 8 analysts have published ratings on DocGo (NASDAQ:DCGO), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 3 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 3 1 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $9.56, a high estimate of $11.00, and a low estimate of $6.50. A decline of 16.87% from the prior average price target is evident i
Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $8 to $6.5.
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in November: Southwest Ideas Conference (November 20th) Lee Bienstock, Chief Executive Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday November 20th at 5:10 PM ET. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum (November 21st) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings at this event. Contact your Can
Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Total revenue for the third quarter of 2024 was $138.7 million, compared to $186.6 million in the third quarter of 2023, a decrease of 26%. The decline was primarily due to the planned wind down of migrant-related progra
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the third quarter ended September 30, 2024 after the markets close on Thursday, November 7, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, November 7, 2024 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) A webcast of the conference call can be accessed under Events on the Investors section of the Company's
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has renewed its contract with Bayhealth – central and southern Delaware's largest healthcare system – for an additional three-year term. This extension is a testament to Ambulnz's proven success supporting Bayhealth with timely, dependable non-emergency transportation services. The Company anticipates completing more than 20,000 trips during the contract term. "Extending our partnership with Bayhealth underscores our commitment to providing high-quality, accessible care in Delaware," said Stan Gitin, SVP of Operations for DocGo. "
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that it has been selected as a finalist for two separate independent awards for its compliance and risk programs. The Company was named a finalist for the 2024 NAVEX Excellence Awards in the Compliance & Risk Program of the Year category and was also named a finalist for the Best Compliance and Ethics Program (small to mid-cap) in Governance Intelligence's Corporate Governance Awards 2024. "We are honored to be named a finalist for both of these industry-leading awards," said Stephen Sugrue, DocGo's Chief Compliance Officer. "This recognition reflects our te
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the expansion of a program to enhance healthcare access for California Medi-Cal enrollees/patients/members. The program aims to re-engage patients with the healthcare system, delivering essential care to underserved communities in Sacramento, San Diego, Riverside, Los Angeles, San Bernadino, and Orange County through a partnership with a top 10 national insurance provider. "This expansion reinforces DocGo's leadership in facilitating the delivery of high-quality, highly-accessible healthcare," said Lee Bienstock, CEO of DocGo. "By leveraging technology and m
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in August and September: Midwest Ideas Conference (August 28th – 29th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deliver a presentation on Wednesday August 28th at 3:45PM. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. Morgan Stanley 22nd Annual Global Healthcare Conference (September 4th – 6th) Lee Bienstock, Chief Executive Officer will hold 1x1 meetings, and participate in a fireside cha
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1 Guidance of $65-$75 Million Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Total revenue for the second quarter of 2024 was $164.9 million, compared to $125.5 million in the second quarter of 2023, an increase of 31%. GAAP gros
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
ARS - DocGo Inc. (0001822359) (Filer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers
DocGo stood out as one of the top companies to meet employee needs. DocGo (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services is pleased to announce that U.S. News & World Report, the global authority in rankings and consumer advice, has named DocGo one of the 2024-2025 Best Companies to Work For. DocGo was rated among the Best Companies to Work For ‑ Northeast on factors contributing to job seekers' decision-making when choosing a workplace that best meets their needs. "A key aspect of DocGo's success is our incredible team of passionate, dedicated professionals, and we're always looking for the best of the best to join us," said Lee Bienstock, CEO of DocGo
DocGo hires Jen McLean and Yong Kim as Vice Presidents DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, today announced the addition of two senior leaders bringing significant experience in large-scale public health program management and value-based care partnerships with health plans. Yong Kim has joined as Vice President of Health Plan Partnerships from his most recent role leading business operations and strategy for CVS Health's population health and care management programs. Jen McLean has joined as Vice President of Government and Public Health Programs from her most recent role as Chief Operating Officer of City Harvest in New York City.
DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, today announced that its medical staffing division that services federal agencies achieved the coveted ISO 9001:2015 certification. This Quality Management Systems ("QMS") standard sets the bar for quality assurance, emphasizing continuous improvement, customer satisfaction, and efficient processes. This certification represents a significant milestone, demonstrating the company's commitment to the highest standards of quality management. "Achieving ISO certification is an important step in our growth trajectory," said Tim Harvey, General Manager at DocGo. "Our team works with the most val
DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona. Beginning in late November, DocGo now operates a mobile clinic to enhance vaccine accessibility in a rural area with limited access to medical resources. Santa Cruz County is designated as a medically underserved area by the Arizona Department of Health Services. This new Santa Cruz clinic expands vaccination access in the county. "By expanding our partnership with the Department of Health in Santa Cruz County, we are not only
DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, announced today that its UK-based subsidiary, Ambulnz Community Partners, has been awarded a 5-year contract to provide emergency and urgent ambulance services for South Central Ambulance Service NHS Foundation Trust. Natalie Lamb, Managing Director of Ambulnz Community Partners, commented: "This is a very proud moment for our group as we continue to expand our portfolio and footprint of higher acuity services in line with our organizational strategy across Berkshire, Oxfordshire, and Buckinghamshire." Ms. Lamb added: "This is the first time SCAS has awarded a 5-year contract to a private provider
New expansion solidifies Ambulnz by DocGo's position as one of the largest ambulance providers in Philadelphia DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, announced today that its Ambulnz subsidiary will provide medical transportation service to Main Line Heath's five-hospital health system in the greater Philadelphia area. The three-year medical transportation contract solidifies Ambulnz's position as one of the largest medical transportation providers in the Philadelphia metro area. Ambulnz estimates that it will provide transportation to more than 12,000 Main Line Health patients annually as part of this contract. With this expansion, Ambu
DocGo (NASDAQ:DCGO), a leading provider of last-mile mobile health services announced that its Board of Directors has appointed Lee Bienstock, who most recently served as the company's President and Chief Operating Officer, to the role of Chief Executive Officer, effective September 15, 2023. "Lee has done an exceptional job transforming DocGo through rapid growth since joining us in March 2022," said Stan Vashovsky, DocGo's co-founder and chairman of its Board of Directors. "I've known Lee for several years, and he's the perfect person to lead DocGo. I look forward to working with him to continue transforming how healthcare is delivered today, and for the future." Bienstock joined DocG
Volume of new business demonstrates strong growth across key mobile health, medical transportation service lines DocGo (NASDAQ:DCGO), a leading provider of last-mile mobile health services, announced today that since the start of 2023 DocGo has had multiple new single and multi-year revenue contract wins as well as contract expansions valued at over $180 million over the next three years. These include new customer relationships with a premier not-for-profit health system serving Philadelphia and its western suburbs, a leading hospital network on Long Island, multiple federally funded hospitals, a Primary Care Network in South West London, UK, as well as expanded relationships with Philade
BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00
Cantor Fitzgerald initiated coverage of DocGo with a rating of Overweight and set a new price target of $11.00
Deutsche Bank initiated coverage of DocGo with a rating of Buy and set a new price target of $11.00
Stifel initiated coverage of DocGo with a rating of Buy and set a new price target of $14.00
Canaccord Genuity initiated coverage of DocGo with a rating of Buy and set a new price target of $13.00
Needham initiated coverage of DocGo with a rating of Buy and set a new price target of $14.00
Northland Capital Markets reiterated coverage of DocGo with a rating of Outperform and set a new price target of $22.00 from $16.00 previously
Barclays initiated coverage of DocGo with a rating of Overweight and set a new price target of $14.00